Adicet Bio (ACET) Amortizatization of Intangibles (2018 - 2026)
Adicet Bio (ACET) posted quarterly Amortizatization of Intangibles of $790000.0 for Q1 2026, down 34.6% year-over-year from $1.2 million in Q1 2025, and down 34.82% quarter-over-quarter from $1.2 million in Q4 2025.
Adicet Bio (ACET) Amortizatization of Intangibles (2018 - 2026) Analysis & Trends
Adicet Bio's Amortizatization of Intangibles history runs 7 years deep, the most recent figure standing at $790000.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles fell 34.6% year-over-year to $790000.0; the TTM figure through Mar 2026 stood at $3.7 million (up 27.78% YoY), while the FY2025 annual figure was $4.1 million, up 145.38% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $790000.0, down from $1.2 million in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $1.4 million in Q4 2024, with the low at $282000.0 in Q3 2024.
- The 3-year median for Amortizatization of Intangibles is $968000.0 (2025), against an average of $935857.1.
- The sharpest annual moves came in 2025 and 2026: Amortizatization of Intangibles surged 150.0% in 2025, then sank 34.6% in 2026.
- Adicet Bio's Amortizatization of Intangibles stood at $1.4 million in 2024, then decreased by 12.55% to $1.2 million in 2025, then sank by 34.82% to $790000.0 in 2026.
- Business Quant data shows ACET's Amortizatization of Intangibles at $790000.0 in Q1 2026, $1.2 million in Q4 2025, and $705000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Adicet Bio | 98.21 Mn | -19.98 Mn | - | 633,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 633,000.00 |
| Jun 30, 2026 | 633,000.00 |
| Mar 31, 2026 | 790,000.00 |
| Mar 31, 2026 | 790,000.00 |
| Dec 31, 2025 | 1.21 Mn |
| Dec 31, 2025 | 1.21 Mn |
| Sep 30, 2025 | 705,000.00 |
| Sep 30, 2025 | 705,000.00 |
| Jun 30, 2025 | 968,000.00 |
| Jun 30, 2025 | 968,000.00 |
| Mar 31, 2025 | 1.21 Mn |
| Mar 31, 2025 | 1.21 Mn |
| Dec 31, 2024 | 1.39 Mn |
| Dec 31, 2024 | 1.39 Mn |
| Sep 30, 2024 | 282,000.00 |
| Sep 30, 2024 | 282,000.00 |
| Jun 30, 2021 | -1,000.00 |
| Jun 30, 2021 | -1,000.00 |
| Mar 31, 2021 | -9,000.00 |
| Mar 31, 2021 | -9,000.00 |